JO3500B1 - الديسموبريسين المستقر - Google Patents
الديسموبريسين المستقرInfo
- Publication number
- JO3500B1 JO3500B1 JOP/2015/0148A JOP20150148A JO3500B1 JO 3500 B1 JO3500 B1 JO 3500B1 JO P20150148 A JOP20150148 A JO P20150148A JO 3500 B1 JO3500 B1 JO 3500B1
- Authority
- JO
- Jordan
- Prior art keywords
- desmopressin
- acceptable salt
- active ingredient
- stabilizing agent
- orally disintegrating
- Prior art date
Links
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 title abstract 4
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 title abstract 4
- 229960004281 desmopressin Drugs 0.000 title abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- 238000004925 denaturation Methods 0.000 abstract 1
- 230000036425 denaturation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
يتعلق الاختراع الحالي باختراع يكون متعلقًا بتركيبة صيدلانية مشتملة على مكون فعال وعامل تثبيت، حيث يكون المكون الفعال عبارة عن ديزمُوبرِيسِين أو ملح مقبول صيدلانيًا منه، وحيث يكون عامل التثبيت عبارة عن صمغ واحد على الأقل، استخدام واحد أو أكثر من الأصماغ لزيادة ثبات تركيبة صيدلانية مشتملة على ديزمُوبرِيسِين أو ملح مقبول صيدلانيًا منه كمكون فعال ضد التمسخ، طريقة لتحضير غشاء رقيق يتحلل عن طريق الفم مشتمل على ديزمُوبرِيسِين أو ملح مقبول صيدلانيًا منه إضافة إلى غشاء رقيق يتحلل عن طريق الفم يمكن الحصول عليه وفقًا لذلك.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020140073067A KR20150144209A (ko) | 2014-06-16 | 2014-06-16 | 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO3500B1 true JO3500B1 (ar) | 2020-07-05 |
Family
ID=53510836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2015/0148A JO3500B1 (ar) | 2014-06-16 | 2015-06-16 | الديسموبريسين المستقر |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20170128521A1 (ar) |
| EP (1) | EP3154516B1 (ar) |
| JP (1) | JP6615130B2 (ar) |
| KR (2) | KR20150144209A (ar) |
| CN (1) | CN106456706B (ar) |
| AR (1) | AR100850A1 (ar) |
| AU (1) | AU2015276247C1 (ar) |
| CA (1) | CA2951768C (ar) |
| CL (1) | CL2016003219A1 (ar) |
| CO (1) | CO2017000354A2 (ar) |
| DK (1) | DK3154516T3 (ar) |
| EA (1) | EA032834B1 (ar) |
| ES (1) | ES2751600T3 (ar) |
| HR (1) | HRP20191746T1 (ar) |
| HU (1) | HUE045395T2 (ar) |
| IL (1) | IL249538A0 (ar) |
| JO (1) | JO3500B1 (ar) |
| LT (1) | LT3154516T (ar) |
| MX (1) | MX374540B (ar) |
| MY (1) | MY182781A (ar) |
| NZ (1) | NZ727388A (ar) |
| PH (1) | PH12016502527A1 (ar) |
| PL (1) | PL3154516T3 (ar) |
| PT (1) | PT3154516T (ar) |
| RS (1) | RS59449B1 (ar) |
| SA (1) | SA516380492B1 (ar) |
| SG (2) | SG11201609374YA (ar) |
| SI (1) | SI3154516T1 (ar) |
| TN (1) | TN2016000561A1 (ar) |
| TW (1) | TWI670070B (ar) |
| UA (1) | UA119776C2 (ar) |
| WO (1) | WO2015193246A1 (ar) |
| ZA (1) | ZA201608020B (ar) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432424B (zh) * | 2021-12-27 | 2023-06-27 | 南通联亚药业股份有限公司 | 一种稳定的铝塑包装去氨加压素片剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| CA2484724C (en) * | 2002-05-07 | 2007-01-16 | Ferring B.V. | Pharmaceutical formulations |
| WO2007083323A2 (en) * | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
| CN100463674C (zh) * | 2006-12-22 | 2009-02-25 | 江苏奥赛康药业有限公司 | 一种氯雷他定口腔速溶膜及其制备方法 |
| TW201422254A (zh) * | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
| US20150306170A1 (en) * | 2012-11-21 | 2015-10-29 | Ferring B.V. | Composition for immediate and extended release |
-
2014
- 2014-06-16 KR KR1020140073067A patent/KR20150144209A/ko active Pending
-
2015
- 2015-06-15 WO PCT/EP2015/063347 patent/WO2015193246A1/en not_active Ceased
- 2015-06-15 SG SG11201609374YA patent/SG11201609374YA/en unknown
- 2015-06-15 SI SI201530936T patent/SI3154516T1/sl unknown
- 2015-06-15 CN CN201580032230.9A patent/CN106456706B/zh active Active
- 2015-06-15 ES ES15734080T patent/ES2751600T3/es active Active
- 2015-06-15 AU AU2015276247A patent/AU2015276247C1/en active Active
- 2015-06-15 KR KR1020177001134A patent/KR102360656B1/ko active Active
- 2015-06-15 MY MYPI2016704613A patent/MY182781A/en unknown
- 2015-06-15 RS RSP20191285 patent/RS59449B1/sr unknown
- 2015-06-15 HU HUE15734080A patent/HUE045395T2/hu unknown
- 2015-06-15 SG SG10201811139UA patent/SG10201811139UA/en unknown
- 2015-06-15 EP EP15734080.3A patent/EP3154516B1/en active Active
- 2015-06-15 CA CA2951768A patent/CA2951768C/en active Active
- 2015-06-15 US US15/318,683 patent/US20170128521A1/en not_active Abandoned
- 2015-06-15 UA UAA201700344A patent/UA119776C2/uk unknown
- 2015-06-15 EA EA201692556A patent/EA032834B1/ru not_active IP Right Cessation
- 2015-06-15 JP JP2016573603A patent/JP6615130B2/ja active Active
- 2015-06-15 HR HRP20191746TT patent/HRP20191746T1/hr unknown
- 2015-06-15 LT LT15734080T patent/LT3154516T/lt unknown
- 2015-06-15 MX MX2016016635A patent/MX374540B/es active IP Right Grant
- 2015-06-15 DK DK15734080.3T patent/DK3154516T3/da active
- 2015-06-15 PL PL15734080T patent/PL3154516T3/pl unknown
- 2015-06-15 TN TN2016000561A patent/TN2016000561A1/en unknown
- 2015-06-15 NZ NZ727388A patent/NZ727388A/en unknown
- 2015-06-15 PT PT157340803T patent/PT3154516T/pt unknown
- 2015-06-16 TW TW104119405A patent/TWI670070B/zh active
- 2015-06-16 AR ARP150101907A patent/AR100850A1/es not_active Application Discontinuation
- 2015-06-16 JO JOP/2015/0148A patent/JO3500B1/ar active
-
2016
- 2016-11-18 ZA ZA2016/08020A patent/ZA201608020B/en unknown
- 2016-12-13 IL IL249538A patent/IL249538A0/en unknown
- 2016-12-13 SA SA516380492A patent/SA516380492B1/ar unknown
- 2016-12-15 CL CL2016003219A patent/CL2016003219A1/es unknown
- 2016-12-16 PH PH12016502527A patent/PH12016502527A1/en unknown
-
2017
- 2017-01-16 CO CONC2017/0000354A patent/CO2017000354A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016016593A (es) | Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos. | |
| MY187047A (en) | Selective pyy compounds and uses thereof | |
| NZ721298A (en) | Pharmaceutical compositions comprising azd9291 | |
| PH12017502376A1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| MX2016011105A (es) | Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos. | |
| EA201691741A1 (ru) | Фармацевтическая композиция | |
| WO2015001541A3 (en) | Pharmaceutical film composition | |
| MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| WO2016006975A3 (en) | Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof | |
| WO2016006974A3 (en) | Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof | |
| EA201890896A1 (ru) | Твердый препарат для перорального применения, содержащий аморфный солифенацин, и способ его получения | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| MX385513B (es) | Composiciones farmaceuticas que comprenden safinamida. | |
| IN2014MU00859A (ar) | ||
| PH12016502527B1 (en) | Stabilized desmopressin | |
| EA201891848A1 (ru) | Фармацевтическая композиция для применения в лечении фиброза | |
| IN2014MU01179A (ar) | ||
| ZA201803722B (en) | Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof | |
| AU2017900496A0 (en) | Compounds for Enhancing the Permeation of Active Pharmaceutical Ingredients through Skin | |
| MX2018007272A (es) | Composicion farmaceutica de liberacion pulsatil que comprende naftazona o una de sus sales. | |
| IN2014MU01178A (ar) | ||
| IN2015MU00907A (ar) | ||
| MX2014008984A (es) | Proceso de obtencion y composicion farmaceutica de fenofibrato capsulas como agente regulador de lipidos para su administracion oral. | |
| UA94512U (uk) | Лікувально-профілактичний засіб імуномодулюючої дії |